Page last updated: 2024-10-27

furazolidone and Leukemia, Myeloid, Acute

furazolidone has been researched along with Leukemia, Myeloid, Acute in 1 studies

Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research Excerpts

ExcerptRelevanceReference
"Furazolidone (FZD) was shown to inhibit bone marrow transformation mediated by several leukemia fusion proteins, including AML1-ETO."1.39A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia. ( Dong, S; Jiang, X; Li, S; Qiu, JJ; So, CW; Sun, L; Sun, X; Wang, X, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, X1
Sun, L1
Qiu, JJ1
Sun, X1
Li, S1
Wang, X1
So, CW1
Dong, S1

Other Studies

1 other study available for furazolidone and Leukemia, Myeloid, Acute

ArticleYear
A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Animals; Antineoplastic Agents; Antitrichomonal Agents; Apoptosis; Biological Assay; Cell Differenti

2013